BioSpace News Archive

Ultra-fast Genetic Test For COVID-19 Created By Bay Area Lab Avellino

Company also preparing to support faster point-of-care testing for COVID-19 in hospitals once available

FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (“FSD Pharma” or the “Company”) today announced that it has taken steps to mitigate the impact of the novel coronavirus SARS-CoV-2 pandemic on its wholly-owned subsidiary, FV Pharma Inc. (“FV Pharma”), a licensed producer under Canada’s Cannabis Act and Regulations, and its facility in Cobourg, Ontario.

IRLAB announced today that a publication based on the results of the clinical phase IIa study with IRL752 in patients with Parkinson’s disease is accepted and now published in the scientific journal Movement Disorders . “External validation of our research and drug development is important. Publication of clinical study results

Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products, today announced Jesse Ledger, Nuvo’s President & Chief Executive Officer and Kelly Demerino, Nuvo’s Interim Chief Financial Officer will present live at LifeSciencesInvestorForum.com on March 26th.

RedHawk Holdings Corp. announced today that it has entered into an agreement (the “Agreement”) with Florida -based Dolphin Medical LLC (“Dolphin”) for the exclusive distribution of RedHawk’

Today, as part of Validic’s efforts to address the global coronavirus (COVID-19) outbreak, the company launched a real-time monitoring solution designed to observe, analyze and triage individuals remotely for the emergence of COVID-19 symptoms.

Elligo Health Research, a healthcare-enabling research organization, is working with Verily to support the Project Baseline COVID-19 Program.

Fusion Pharmaceuticals Inc., a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines to treat a broad range of cancers, today announced the appointment of James J. O’Leary, M.D., as chief medical officer (CMO).

Life Spine announced that in partnership with Gizmo Medical they are currently working on a production quantity of surgical masks and gowns and identifying ways to scale other medical equipment to meet the growing and urgent demand in the United States.